Youming Zhang
Direktor/Vorstandsmitglied bei FUFENG GROUP LIMITED
Aktive Positionen von Youming Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FUFENG GROUP LIMITED | Direktor/Vorstandsmitglied | 01.04.2021 | - |
| Independent Dir/Board Member | 01.04.2021 | - | |
| Shandong University | Corporate Officer/Principal | - | - |
Karriereverlauf von Youming Zhang
Ehemalige bekannte Positionen von Youming Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gene Bridges GmbH
 Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Technik-/Wissenschafts-/F&E-Leiter | - | 01.01.2013 |
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - | - |
Ausbildung von Youming Zhang
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Xiamen University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistik
International
| China | 5 |
| Deutschland | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 6 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FUFENG GROUP LIMITED | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
Gene Bridges GmbH
Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
- Börse
- Insiders
- Youming Zhang
- Erfahrung
